UnitedHealth Group Incorporated (NYSE:UNH)‘s stock had its “buy” rating reissued by investment analysts at Cantor Fitzgerald in a report issued on Tuesday.

Other equities analysts also recently issued reports about the stock. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $190.00 target price on shares of UnitedHealth Group in a research note on Monday, July 10th. Credit Suisse Group reaffirmed an “outperform” rating and set a $200.00 target price (up from $195.00) on shares of UnitedHealth Group in a research note on Thursday, July 13th. Citigroup Inc. lifted their target price on shares of UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Royal Bank Of Canada reaffirmed a “buy” rating and set a $212.00 target price on shares of UnitedHealth Group in a research note on Thursday, July 20th. Finally, Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, June 19th. One investment analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $203.41.

Shares of UnitedHealth Group (NYSE:UNH) opened at 195.88 on Tuesday. The stock has a market cap of $189.39 billion, a P/E ratio of 23.53 and a beta of 0.64. UnitedHealth Group has a 52-week low of $132.39 and a 52-week high of $196.88. The firm’s 50-day moving average price is $191.39 and its 200-day moving average price is $177.02.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. The firm had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.96 earnings per share. Equities analysts predict that UnitedHealth Group will post $9.86 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Incorporated (UNH) Rating Reiterated by Cantor Fitzgerald” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.watchlistnews.com/unitedhealth-group-incorporated-unh-rating-reiterated-by-cantor-fitzgerald/1532740.html.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares in the company, valued at approximately $348,700,935.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the transaction, the director now owns 60,516 shares of the company’s stock, valued at approximately $10,816,629.84. The disclosure for this sale can be found here. Insiders have sold a total of 30,540 shares of company stock valued at $5,748,970 in the last quarter. 0.89% of the stock is currently owned by company insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of UNH. Eastern Bank boosted its position in UnitedHealth Group by 1.0% in the first quarter. Eastern Bank now owns 5,384 shares of the healthcare conglomerate’s stock valued at $883,000 after buying an additional 51 shares during the period. Fox Run Management L.L.C. boosted its position in shares of UnitedHealth Group by 187.7% in the first quarter. Fox Run Management L.L.C. now owns 4,316 shares of the healthcare conglomerate’s stock valued at $708,000 after buying an additional 2,816 shares during the last quarter. Tompkins Financial Corp boosted its position in shares of UnitedHealth Group by 52.2% in the first quarter. Tompkins Financial Corp now owns 7,115 shares of the healthcare conglomerate’s stock valued at $917,000 after buying an additional 2,440 shares during the last quarter. Cribstone Capital Management LLC boosted its position in shares of UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares during the last quarter. Finally, CHICAGO TRUST Co NA boosted its position in shares of UnitedHealth Group by 1.6% in the first quarter. CHICAGO TRUST Co NA now owns 3,560 shares of the healthcare conglomerate’s stock valued at $584,000 after buying an additional 55 shares during the last quarter. Institutional investors own 86.21% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.